PepGen: Upgrade To 'Buy' On PGN-EDODM1 Splicing Data Comeback And 2027 Milestones

🇺🇸 Seeking Alpha (US) —
PepGen: Upgrade To 'Buy' On PGN-EDODM1 Splicing Data Comeback And 2027 Milestones

AI Summary

The article recommends upgrading PepGen to a “Buy,” citing a recovery in PGN-EDODM1 splicing data and milestones expected in 2027. The title does not provide further trial details or financial analysis.

Markets Health PepGen PGN-EDODM1 splicing data biotechnology investment rating 2027 milestones

Read original source →